Austrian-Czechia union of regenerative medicine for acute and chronic wounds ACCURE

ACCURE - Austrian-Czechia union of regenerative medicine for acute and chronic wounds

ACCURE 3D printed in vitro skin model for drug testing

ACCURE - 3D printed In vitro skin model for drug testing

The main goal of the 3-years project ACCURE is a cross-border cooperation between Austrian and Czech partners in the "Research and Innovation" priority in the field of medicine and biotechnology. Universities (CEITEC Brno University of technology, Brno, CZ, Masaryk University, Brno, CZ and Johannes Kepler University (Linz, AT), research institutions (Profactor, Steyr, AT) and private companies (Enantis, Brno, CZ and Tiger, Wels, AT) are involved. ACCURE focuses on the development of a new 3D-printed in vitro full-thickness skin model using innovative technologies and biotechnology that faithfully imitates the structure and function of the skin. This model will be used for testing drugs and therapeutic substances, e.g. for the healing of acute and chronic wounds (diabetic ulcers), healing of eczema, and other skin diseases, or for testing cosmetics, accelerating development of new drugs and materials, and avoiding the use of animal models, in line with the principles of the 3Rs (Replacement, Reduction and Refinements).

ACCURE - ATCZ00083

Supported from EFRR: € 983.274,61

Project duration: 1.7.2024 – 30.6.2027

Project partners

CEITEC BUT

PROFACTOR

MUNI

JKU

Enantis

TIGER